Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Modulation of cellular apoptosis with apoptotic protease-activating factor 1 (Apaf-1) inhibitors.

Authors: Mondragon, L  Orzaez, M  Sanclimens, G  Moure, A  Arminan, A  Sepulveda, P  Messeguer, A  Vicent, MJ  Perez-Paya, E 
Citation: Mondragon L, etal., J Med Chem. 2008 Feb 14;51(3):521-9. Epub 2008 Jan 16.
Pubmed: (View Article at PubMed) PMID:18197610
DOI: Full-text: DOI:10.1021/jm701195j

The programmed cell death or apoptosis plays both physiological and pathological roles in biology. Anomalous activation of apoptosis has been associated with malignancies. The intrinsic mitochondrial pathway of apoptosis activation occurs through a multiprotein complex named the apoptosome. We have discovered molecules that bind to a central protein component of the apoptosome, Apaf-1, and inhibits its activity. These new first-in-class apoptosome inhibitors have been further improved by modifications directed to enhance their cellular penetration to yield compounds that decrease cell death, both in cellular models of apoptosis and in neonatal rat cardiomyocytes under hypoxic conditions.


Gene Ontology Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 2325741
Created: 2010-06-08
Species: All species
Last Modified: 2010-06-08
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.